Alumis Inc IPOs Tomorrow, Here's What You Need To Know

Alumis Inc ALMS IPO will take place June, 28 on the NASDAQ exchange under the ticker ALMS.

The company is offering shares at an expected price between $16.00 and $18.00 per share with an insider lock-up period of 180 days ending on December 25, 2024.

See also: Benzinga IPO Calendar

About Alumis Inc

Alumis is a clinical-stage biopharmaceutical company developing oral therapies using a precision approach to optimize outcomes and transform the lives of patients with immune-mediated diseases. Leveraging its precision data analytics and a multi-platform approach, Alumis is advancing a pipeline of oral therapies designed to address immune dysfunction

See also: Benzinga's Most Shorted Stocks

This article was generated by Benzinga's automated content engine and reviewed by an editor.